Gland Pharma Acquires Gland US to Streamline Structure

Gland Pharma Limited's Board of Directors has approved the acquisition of 100% equity share capital of Gland Pharma USA Inc. (Gland US) from its wholly-owned subsidiary, Gland Pharma International Pte. Ltd. This move will make Gland US a direct wholly-owned subsidiary of Gland Pharma Limited, simplifying the corporate structure by removing multiple layers. The acquisition is considered a related party transaction but is being conducted on an arm's length basis with a valuation by an independent expert. Gland US reported nil turnover for FY ending March 31, 2026, and has a share capital of USD 500,000. The company stated there is no material impact on its overall business or operations.